Recent progress in N6-methyladenosine modification in ocular surface diseases
- PMID: 37077483
- PMCID: PMC10089897
- DOI: 10.18240/ijo.2023.04.20
Recent progress in N6-methyladenosine modification in ocular surface diseases
Abstract
N6-methyladenosine (m6A) modification is a reversible process promoted by "writers", inhibited by "erasers", and processed by "readers". During the last decade, increasing emphasis has been placed on the underlying roles of m6A modification owing to their great importance in biological significance. The abnormal regulation of m6A modification will lead to aberrant cellular behavior and various diseases. Recently, studies have demonstrated that m6A modification is closely associated with the genesis and progression of ocular surface diseases (OSDs). This review focus on the role of m6A modification and research progress in OSDs including fungal keratitis, herpes simplex keratitis, immune-related keratoconjunctival diseases, pterygium, ocular chemical burns, and Graves' ophthalmopathy, which may provide new insights into and prospective applications for OSDs.
Keywords: N6-methyladenosine; epigenetics; m6A modification; ocular surface diseases.
International Journal of Ophthalmology Press.
Similar articles
-
N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury.Front Cell Neurosci. 2022 Sep 23;16:989637. doi: 10.3389/fncel.2022.989637. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36212687 Free PMC article. Review.
-
The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.Mol Biol Rep. 2023 Oct;50(10):8691-8703. doi: 10.1007/s11033-023-08575-2. Epub 2023 Aug 20. Mol Biol Rep. 2023. PMID: 37598390 Free PMC article. Review.
-
Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.Front Oncol. 2021 Jan 21;10:623634. doi: 10.3389/fonc.2020.623634. eCollection 2020. Front Oncol. 2021. PMID: 33552994 Free PMC article. Review.
-
Role of m6A writers, erasers and readers in cancer.Exp Hematol Oncol. 2022 Aug 9;11(1):45. doi: 10.1186/s40164-022-00298-7. Exp Hematol Oncol. 2022. PMID: 35945641 Free PMC article. Review.
-
Association of N6-methyladenosine with viruses and related diseases.Virol J. 2019 Nov 11;16(1):133. doi: 10.1186/s12985-019-1236-3. Virol J. 2019. PMID: 31711514 Free PMC article. Review.
Cited by
-
Characterization of N6-methyladenosine long non-coding RNAs in sporadic congenital cataract and age-related cataract.Int J Ophthalmol. 2024 Nov 18;17(11):1973-1986. doi: 10.18240/ijo.2024.11.02. eCollection 2024. Int J Ophthalmol. 2024. PMID: 39559306 Free PMC article.
-
CD3ε of a pan T cell marker involved in mouse Aspergillus fumigatus keratitis.Int J Ophthalmol. 2024 Apr 18;17(4):616-624. doi: 10.18240/ijo.2024.04.03. eCollection 2024. Int J Ophthalmol. 2024. PMID: 38638265 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources